bisbenzimidazole has been researched along with Anoxia-Ischemia, Brain in 2 studies
Bisbenzimidazole: A benzimidazole antifilarial agent; it is fluorescent when it binds to certain nucleotides in DNA, thus providing a tool for the study of DNA replication; it also interferes with mitosis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Unal Cevik, I | 1 |
| Dalkara, T | 1 |
| Sheng, WW | 1 |
| Li, CT | 1 |
| Zhang, WP | 1 |
| Yuan, YM | 1 |
| Hu, H | 1 |
| Fang, SH | 1 |
| Zhang, L | 1 |
| Wei, EQ | 1 |
2 other studies available for bisbenzimidazole and Anoxia-Ischemia, Brain
| Article | Year |
|---|---|
Intravenously administered propidium iodide labels necrotic cells in the intact mouse brain after injury.
Topics: Animals; Apoptosis; Biomarkers; Bisbenzimidazole; Brain; Brain Injuries; Cell Death; Hypoxia-Ischemi | 2003 |
Distinct roles of CysLT1 and CysLT2 receptors in oxygen glucose deprivation-induced PC12 cell death.
Topics: Acetates; Animals; Bisbenzimidazole; Cell Death; Cyclopropanes; Flow Cytometry; Glucose; Hypoxia-Isc | 2006 |